National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, Beijing, China.
Microbiol Spectr. 2023 Aug 17;11(4):e0126523. doi: 10.1128/spectrum.01265-23. Epub 2023 Jun 28.
This study evaluated the diagnostic performance of stool-based Xpert MTB/RIF Ultra assay (Xpert-Ultra, Cepheid, USA) against other tests using respiratory tract specimens (RTS) and stool for diagnosing adult pulmonary tuberculosis. A prospective study on patients with presumptive pulmonary tuberculosis was conducted in Beijing Chest Hospital from June to November 2021. The smear test, MGIT960 liquid culture, and Xpert MTB/RIF (Xpert, Cepheid, USA) were performed simultaneously on RTS, and smear, culture Xpert, and Xpert-Ultra were performed simultaneously using stool. Patients were grouped based on the outcomes of RTS examination and other tests. In total, 130 eligible patients were enrolled that included 96 pulmonary tuberculosis and 34 non-TB patients. The sensitivity of smear, culture, Xpert, and Xpert-Ultra using stool was 10.96%, 23.28%, 60.27%, and 79.45%, respectively. The specificities of Xpert and Xpert-Ultra using RTS and stool were all 100% (34/34). Notably, all five confirmed cases detected by bronchoalveolar lavage fluid (BALF) examination yielded Xpert-Ultra positive outcomes with the stool specimens. Xpert-Ultra assay on stool sample harbors comparable sensitivity with Xpert on RTS. Thus, the Xpert-Ultra testing on stool specimens could be a very promising and practical strategy to improve pulmonary tuberculosis (PTB) diagnosis, especially among patients who could not expectorate sputum. This study is aimed at assessing the value of Xpert MTB/RIF Ultra (Xpert-Ultra) in PTB on stool in adult in low HIV settings and Xpert-Ultra assay on stool sample harboring comparable sensitivity with Xpert MTB/RIF on respiratory tract specimens. Although the yield in stool samples by Xpert-Ultra is lower than RTS, it may be useful in detecting disease in presumptive TB patients who cannot expectorate sputum and are not open to BALF collection. In addition, Xpert-Ultra with a "trace call" on stool in adult was highly supportive of PTB.
本研究评估了基于粪便的 Xpert MTB/RIF Ultra 检测(Xpert-Ultra,Cepheid,美国)与使用呼吸道标本(RTS)和粪便进行的其他检测在诊断成人肺结核方面的诊断性能。2021 年 6 月至 11 月,在北京胸科医院对疑似肺结核患者进行了一项前瞻性研究。同时对 RTS 进行了涂片检查、MGIT960 液体培养和 Xpert MTB/RIF(Xpert,Cepheid,美国)检测,同时对粪便进行了涂片、培养 Xpert 和 Xpert-Ultra 检测。根据 RTS 检查和其他检查的结果对患者进行分组。共有 130 名符合条件的患者入组,其中 96 例为肺结核患者,34 例为非结核患者。使用粪便的涂片、培养、Xpert 和 Xpert-Ultra 的敏感性分别为 10.96%、23.28%、60.27%和 79.45%。使用 RTS 和粪便的 Xpert 和 Xpert-Ultra 的特异性均为 100%(34/34)。值得注意的是,支气管肺泡灌洗液(BALF)检查确诊的 5 例患者的粪便标本均为 Xpert-Ultra 阳性。粪便样本的 Xpert-Ultra 检测与 RTS 上的 Xpert 具有相当的敏感性。因此,粪便标本的 Xpert-Ultra 检测可能是一种很有前途和实用的策略,可以提高肺结核(PTB)的诊断率,特别是在那些无法咳出痰液的患者中。本研究旨在评估 Xpert MTB/RIF Ultra(Xpert-Ultra)在 HIV 水平较低的成人粪便中对肺结核的价值,以及粪便样本的 Xpert-Ultra 检测与呼吸道标本的 Xpert MTB/RIF 具有相当的敏感性。虽然 Xpert-Ultra 对粪便样本的检出率低于 RTS,但对于那些无法咳出痰液且无法接受支气管肺泡灌洗采集的疑似结核病患者,它可能具有一定的诊断价值。此外,成人粪便中 Xpert-Ultra 出现“微量信号”高度提示肺结核。